Sonova Holding Valuation

Is SOON undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SOON when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SOON (CHF263) is trading below our estimate of fair value (CHF466.18)

Significantly Below Fair Value: SOON is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for SOON?

Other financial metrics that can be useful for relative valuation.

SOON key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue4.7x
Enterprise Value/EBITDA19.9x
PEG Ratio2.5x

Price to Earnings Ratio vs Peers

How does SOON's PE Ratio compare to its peers?

The above table shows the PE ratio for SOON vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average53.7x
STMN Straumann Holding
94x23.7%CHF23.1b
MOVE Medacta Group
51.9x22.6%CHF2.4b
METN Metall Zug
26.8x39.3%CHF596.3m
ALC Alcon
42.1x10.7%CHF37.1b
SOON Sonova Holding
26.1x10.5%CHF15.7b

Price-To-Earnings vs Peers: SOON is good value based on its Price-To-Earnings Ratio (26.1x) compared to the peer average (53.7x).


Price to Earnings Ratio vs Industry

How does SOON's PE Ratio compare vs other companies in the European Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a16.8%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a16.8%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: SOON is good value based on its Price-To-Earnings Ratio (26.1x) compared to the European Medical Equipment industry average (33.3x).


Price to Earnings Ratio vs Fair Ratio

What is SOON's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SOON PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio26.1x
Fair PE Ratio36.5x

Price-To-Earnings vs Fair Ratio: SOON is good value based on its Price-To-Earnings Ratio (26.1x) compared to the estimated Fair Price-To-Earnings Ratio (36.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SOON forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF263.00
CHF271.82
+3.4%
12.2%CHF325.00CHF200.00n/a17
Mar ’25CHF276.50
CHF270.59
-2.1%
13.4%CHF325.00CHF200.00n/a17
Feb ’25CHF279.10
CHF267.06
-4.3%
14.7%CHF325.00CHF200.00n/a16
Jan ’25CHF274.40
CHF257.07
-6.3%
12.7%CHF320.00CHF200.00n/a15
Dec ’24CHF255.80
CHF259.75
+1.5%
13.4%CHF340.00CHF200.00n/a16
Nov ’24CHF217.30
CHF249.50
+14.8%
15.8%CHF340.00CHF195.00n/a16
Oct ’24CHF217.70
CHF252.81
+16.1%
16.3%CHF340.00CHF195.00n/a16
Sep ’24CHF233.10
CHF253.59
+8.8%
15.4%CHF331.00CHF195.00n/a17
Aug ’24CHF242.50
CHF253.59
+4.6%
15.4%CHF331.00CHF195.00n/a17
Jul ’24CHF238.20
CHF254.76
+7.0%
14.8%CHF331.00CHF195.00n/a17
Jun ’24CHF235.70
CHF248.91
+5.6%
14.6%CHF320.00CHF180.30n/a18
May ’24CHF281.80
CHF257.58
-8.6%
15.1%CHF330.00CHF180.30n/a16
Apr ’24CHF268.60
CHF257.33
-4.2%
15.2%CHF330.00CHF180.30n/a16
Mar ’24CHF231.40
CHF258.71
+11.8%
15.4%CHF330.00CHF180.30CHF276.5016
Feb ’24CHF233.40
CHF258.71
+10.8%
15.4%CHF330.00CHF180.30CHF279.1016
Jan ’24CHF219.30
CHF286.21
+30.5%
20.7%CHF450.00CHF180.30CHF274.4016
Dec ’23CHF248.10
CHF291.29
+17.4%
20.0%CHF450.00CHF180.30CHF255.8015
Nov ’23CHF234.80
CHF305.21
+30.0%
16.9%CHF450.00CHF255.00CHF217.3014
Oct ’23CHF220.00
CHF335.00
+52.3%
13.6%CHF450.00CHF257.00CHF217.7013
Sep ’23CHF252.60
CHF338.08
+33.8%
13.8%CHF450.00CHF257.00CHF233.1013
Aug ’23CHF341.00
CHF372.00
+9.1%
11.8%CHF450.00CHF290.00CHF242.5012
Jul ’23CHF309.60
CHF373.92
+20.8%
15.6%CHF470.00CHF257.00CHF238.2013
Jun ’23CHF330.40
CHF366.88
+11.0%
17.0%CHF470.00CHF250.00CHF235.7016
May ’23CHF355.20
CHF371.18
+4.5%
19.4%CHF470.00CHF227.00CHF281.8017
Apr ’23CHF386.70
CHF369.38
-4.5%
20.0%CHF470.00CHF227.00CHF268.6016
Mar ’23CHF358.30
CHF366.88
+2.4%
20.0%CHF470.00CHF227.00CHF231.4016

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.